- Home
- AIRT vs MDAI Comparison
AIRT vs MDAI Comparison
Compare AIRT & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRT
- MDAI
- Stock Information
- Founded
- AIRT 1980
- MDAI 2013
- Country
- AIRT United States
- MDAI United States
- Employees
- AIRT N/A
- MDAI N/A
- Industry
- AIRT Air Freight/Delivery Services
- MDAI Medical/Dental Instruments
- Sector
- AIRT Consumer Discretionary
- MDAI Health Care
- Exchange
- AIRT Nasdaq
- MDAI Nasdaq
- Market Cap
- AIRT 59.0M
- MDAI 69.0M
- IPO Year
- AIRT N/A
- MDAI N/A
- Fundamental
- Price
- AIRT $22.70
- MDAI $2.60
- Analyst Decision
- AIRT
- MDAI Strong Buy
- Analyst Count
- AIRT 0
- MDAI 2
- Target Price
- AIRT N/A
- MDAI $4.75
- AVG Volume (30 Days)
- AIRT 4.1K
- MDAI 787.8K
- Earning Date
- AIRT 08-13-2025
- MDAI 08-11-2025
- Dividend Yield
- AIRT N/A
- MDAI N/A
- EPS Growth
- AIRT N/A
- MDAI N/A
- EPS
- AIRT N/A
- MDAI N/A
- Revenue
- AIRT $291,850,000.00
- MDAI $29,962,000.00
- Revenue This Year
- AIRT N/A
- MDAI N/A
- Revenue Next Year
- AIRT N/A
- MDAI $15.15
- P/E Ratio
- AIRT N/A
- MDAI N/A
- Revenue Growth
- AIRT 1.75
- MDAI 55.21
- 52 Week Low
- AIRT $14.56
- MDAI $0.82
- 52 Week High
- AIRT $26.70
- MDAI $3.25
- Technical
- Relative Strength Index (RSI)
- AIRT 54.67
- MDAI 54.14
- Support Level
- AIRT $21.87
- MDAI $2.43
- Resistance Level
- AIRT $26.70
- MDAI $2.75
- Average True Range (ATR)
- AIRT 1.02
- MDAI 0.21
- MACD
- AIRT 0.04
- MDAI -0.06
- Stochastic Oscillator
- AIRT 30.56
- MDAI 29.07
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.